[Other] BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study |
Reward20points
Best Answer
3 day(s) ago
|
| |
post
reply
points
810
10
MRI-guided interventional procedures: current use and future potentials
20
African American English and Early Literacy: A Comparison of Approaches to Quantifying Nonmainstream Dialect Use
30
Catastrophic Health Expenditure in Patients with Lower-Extremity Orthopaedic Trauma
20
Composite Scaffolds for Bone Tissue Engineering
20
Generalized Knowledge Distillation for Topic Models
